O. Pipek

发表

Nationwide lung cancer screening with low-dose computed tomography: implementation and first results of the HUNCHEST screening program

L. Rojkó, G. Ostoros, K. Hoetzenecker, 2022, European Radiology.

Expression patterns and prognostic relevance of subtype‐specific transcription factors in surgically resected small‐cell lung cancer: an international multicenter study

F. Hirsch, H. Popper, Z. Lohinai, 2022, The Journal of pathology.

Identification of mutations in SARS-CoV-2 PCR primer regions

Carla A. Cummins, G. Cochrane, M. Koopmans, 2022, Scientific Reports.

Fast and accurate mutation detection in whole genome sequences of multiple isogenic samples with IsoMut

Z. Szallasi, I. Csabai, G. Tusnády, 2017, BMC Bioinformatics.

Investigating the Prognostic Relevance of Tumor Immune Microenvironment and Immune Gene Assembly in Breast Carcinoma Subtypes

A. Tőkés, J. Kulka, O. Rusz, 2022, Cancers.

Patterns of Somatic Variants in Colorectal Adenoma and Carcinoma Tissue and Matched Plasma Samples from the Hungarian Oncogenome Program

I. Csabai, A. Kalmár, B. Molnár, 2023, Cancers.

Long-term treatment with the PARP inhibitor niraparib does not increase the mutation load in cell line models and tumour xenografts

Z. Szallasi, I. Csabai, Yonghong Xiao, 2018, British Journal of Cancer.

The Driverless Triple-Wild-Type (BRAF, RAS, KIT) Cutaneous Melanoma: Whole Genome Sequencing Discoveries

J. Tímár, D. Alpár, S. Kárpáti, 2023, Cancers.

A revised multi-tissue, multi-platform epigenetic clock model for methylation array data

I. Csabai, O. Pipek, 2022, Journal of Mathematical Chemistry.

Folic Acid Treatment Directly Influences the Genetic and Epigenetic Regulation along with the Associated Cellular Maintenance Processes of HT-29 and SW480 Colorectal Cancer Cell Lines

I. Csabai, A. Kalmár, B. Molnár, 2022, Cancers.

Genomic Landscape of Normal and Breast Cancer Tissues in a Hungarian Pilot Cohort

Z. Szallasi, I. Csabai, A. Tőkés, 2023, International journal of molecular sciences.

Comparative expression analysis of immune-related markers in surgically resected lung neuroendocrine neoplasms.

B. Döme, K. Schelch, V. Laszlo, 2023, Lung cancer.

Liquid biopsy-based monitoring of residual disease in multiple myeloma by analysis of the rearranged immunoglobulin genes–A feasibility study

I. Csabai, F. Uher, I. Kacskovics, 2023, PloS one.

P2.04-08 Platinum-Based Chemotherapy is Associated with Altered PD-L1 Expression in Lung Cancer

Z. Szallasi, L. Reiniger, L. Rojkó, 2018, Journal of Thoracic Oncology.

Systematic detection of co-infection and intra-host recombination in more than 2 million global SARS-CoV-2 samples (preprint)

M. Koopmans, I. Csabai, J. Stéger, 2023 .

Fast and accurate mutation detection in whole genome sequences of multiple isogenic samples with IsoMut

Z. Szallasi, I. Csabai, G. Tusnády, 2017, BMC Bioinformatics.

Loss of BRCA1 or BRCA2 markedly increases the rate of base substitution mutagenesis and has distinct effects on genomic deletions

I Csabai, Z. Szallasi, I. Csabai, 2016, Oncogene.

Claudin expression in pulmonary adenoid cystic carcinoma and mucoepidermoid carcinoma

Z. Szallasi, M. Gyulai, J. Moldvay, 2023, Pathology oncology research : POR.

Chemotherapy treatment is associated with altered PD-L1 expression in lung cancer patients

Z. Szallasi, B. Döme, L. Reiniger, 2018, Journal of Cancer Research and Clinical Oncology.

PD-L1 Expression of Lung Cancer Cells, Unlike Infiltrating Immune Cells, Is Stable and Unaffected by Therapy During Brain Metastasis.

Z. Szallasi, B. Döme, L. Reiniger, 2019, Clinical lung cancer.

Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal

Zoltan Szallasi, Ashish Chandra, Adam Huffman, 2018, Cell.

Biologically informed deep learning for explainable epigenetic clocks

I. Csabai, S. Spisák, O. Pipek, 2024, Scientific reports.

Expression patterns of novel immunotherapy targets in intermediate- and high-grade lung neuroendocrine neoplasms

B. Döme, K. Schelch, J. Fillinger, 2024, Cancer immunology, immunotherapy : CII.

The landscape of small cell lung cancer metastases: Organ specificity and timing

O. Pipek, J. Moldvay, M. Rezeli, 2021, Thoracic cancer.

New insights into the impact of primary lung adenocarcinoma location on metastatic sites and sequence: A multicenter cohort study.

Z. Szallasi, I. Csabai, B. Döme, 2018, Lung cancer.

Identification of mutations in SARS-CoV-2 PCR primer regions

Carla A. Cummins, G. Cochrane, M. Koopmans, 2022, Scientific Reports.

Evaluating the significance of density, localization, and PD-1/PD-L1 immunopositivity of mononuclear cells in the clinical course of lung adenocarcinoma patients with brain metastasis

Z. Szallasi, C. Swanton, B. Döme, 2017, Neuro-oncology.

EGFR variant allele frequency predicts EGFR-TKI efficacy in lung adenocarcinoma: a multicenter study

Z. Szallasi, V. Téglási, O. Pipek, 2021, Translational lung cancer research.

S-Adenosylmethionine Treatment of Colorectal Cancer Cell Lines Alters DNA Methylation, DNA Repair and Tumor Progression-Related Gene Expression

I. Csabai, A. Kalmár, B. Molnár, 2020, Cells.

A comprehensive survey of the mutagenic impact of common cancer cytotoxics

Gábor E. Tusnády, Zoltan Szallasi, István Csabai, 2016, Genome Biology.

Tumor necrosis correlates with PD-L1 and PD-1 expression in lung adenocarcinoma

Z. Szallasi, B. Döme, L. Reiniger, 2019, Acta oncologica.